Dr. Reddys Laboratories Ltd.

Dr Reddy's Laboratories is planning to launch Molflu (Molnupiravir) at Rs 35 per capsule to treat COVID-19 in the country. With 10 capsules per strip, the total course of 40 capsules over 5 days would cost Rs 1,400, making it among the most affordable treatment options available to patients. Molflu will be manufactured at a USFDA-approved facility, and the drug maker has made adequate capacity preparations to ensure that it is able to help patients in need.  

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.